Timing of administration of prophylactic antibiotics for caesarean section: a systematic review and meta-analysis

H Baaqeel, R Baaqeel, H Baaqeel, R Baaqeel

Abstract

Background: Prophylactic antibiotics reduce infectious morbidity from caesarean section. The timing of their administration, however, is a matter of controversy.

Objectives: To examine maternal and neonatal infectious morbidity in women receiving preoperative prophylaxis compared with those receiving intraoperative administration.

Search strategy: Medline, Embase, Current Controlled Trials and Cochrane Central were searched from their inception dates to December 2011.

Selection criteria: Randomised controlled trials of a single dose of any antibiotic comparing preoperative with intraoperative administration were selected.

Data collection and analysis: Trial characteristics, outcomes and quality measures, based on the Cochrane tool for risk of bias, were independently extracted. The random effect model of DerSimonian and Laird to estimate relative risks (RRs) for maternal and neonatal outcomes was used.

Main results: Six trials met the inclusion criteria, reporting on 2313 women and 2345 newborns. Preoperative administration was associated with a significant 41% reduction in the rate of endometritis compared with intraoperative administration (RR 0.59; 95% confidence interval [95% CI] 0.37-0.94; I2 0%). In the preoperative group, there were nonsignificant reductions in the rates of wound infection (RR 0.71; 95% CI 0.44-1.14; I2 0%), maternal febrile morbidity (RR 0.94; 95% CI 0.46-1.95; I2 0%), neonatal sepsis (RR 0.81; 95% CI 0.47-1.41; I2 0%), neonatal septic work-up (RR 0.93; 95% CI 0.71-1.21; I2 0%) and neonatal intensive-care unit admission (RR 0.92; 95% CI 0.65-1.28; I2 0%). There were nonsignificant increases in the rates of maternal pyelonephritis (RR 1.09; 95% CI 0.49-2.43; I2 0%) and neonatal pneumonia (RR 3.36; 95% CI 0.55-20.47; I2 0%).

Conclusions: Compared with intraoperative administration, preoperative antibiotics significantly reduce the rate of endometritis. The lack of neonatal adverse effects should be cautiously interpreted given the limited power of the trials to detect such effects.

© 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG.

Figures

Figure 1
Figure 1
Study selection flow chart.
Figure 2
Figure 2
Forest plot showing results of the meta-analysis for maternal outcomes.
Figure 3
Figure 3
Forest plot showing results of the meta-analysis for neonatal outcomes.

References

    1. Smaill F, Hofmeyr GJ. Antibiotic prophylaxis regimens and drugs for cesarean section. The Cochrane Database of Systematic Reviews. 1996;2(Issue 2) Art. No.:CD001136. DOI: .
    1. Hopkins L, Smaill F. Antibiotic prophylaxis regimens and drugs for cesarean section. The Cochrane Database of Systematic Reviews. 1999. Art. No.:CD001136. DOI: .
    1. Festin M, Laopaiboon M, Pattanittum P, Ewens M, Henderson-Smart D, Crowther C. Caesarean section in four South East Asian countries: reasons for, rates, associated care practices and health outcomes. BMC Pregnancy Childbirth. 2009;9:17–43.
    1. Tita A, Rouse D, Blackwell S, Saade G, Spong C, Andrews W. Emerging concepts in antibiotic prophylaxis for cesarean delivery. a systematic review. Obstet Gynecol. 2009;113:675–82.
    1. Doss AE, Davidson JD, Cliver SP, Wetta LAL, Andrews WW, Tita ATN. Antibiotic prophylaxis for cesarean delivery: survey of maternal-fetal medicine physicians in the US. J Matern Fetal Neonatal Med. 2012;25:1264–6.
    1. Classen D, Evans R, Pestotnik S, Horn S, Menlove R, Burke J. The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med. 1992;326:281–6.
    1. Mitchell T, Pearlman M, Chapman R, Bhatt-Mehta V, Faix R. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol. 2001;98:1075–9.
    1. Jaure′guy F, Carton M, Panel P, Foucaud P, Butel M, Doucet-Populaire F. Effects of intrapartum penicillin prophylaxis on intestinal bacterial colonization in infants. J Clin Microbiol. 2004;42:5184–8.
    1. Balter S, Zell E, O'Brien K, Roome A, Noga H, Schuchat A. Impact of intrapartum antibiotics on the care and evaluation of the neonate. Pediatr Infect Dis J. 2003;22:853–7.
    1. Edwards R, Jamie W, Sterner D, Gentry S, Counts K, Duff P. Intrapartum antibiotic prophylaxis and early-onset neonatal sepsis patterns. Infect Dis Obstet Gynecol. 2003;11:221–6.
    1. Schrag S, Hadler J, Arnold K, Martell-Cleary P, Reingold A, Schuchat A. Risk factors for invasive, early-onset escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics. 2006;118:570–6.
    1. Terrone D, Rinehart B, Einstein M, Britt L, Martin J, Perry K. Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration. Am J Obstet Gynecol. 1999;180:1345–8.
    1. Towers C, Carr M, Padilla G, Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol. 1998;179:879–83.
    1. McKeever TMLS, Smith C, Hubbard R. The importance of prenatal exposures on the development of allergic disease: a birth cohort study using the West Midlands General Practice Database. Am J Respir Crit Care Med. 2002;166:827–32.
    1. Costantine M, Rahman M, Ghulmiyah L, Byers B, Longo M, Wen T, et al. Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. Am J Obstet Gynecol. 2008;199:301–6.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9.
    1. Brozek J, Oxman A, Schünemann H. GradePro[program] V, 3.6. 2008.
    1. Begg C, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.
    1. Egger M, Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
    1. Review Manager (RevMan) Copenhagen: 2008. [program]. 5.0.21 version.
    1. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol. 2006;6 doi: .
    1. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG. MIX: comprehensive free software for meta-analysis of causal research data. Version 1.7. [ ], 2008.
    1. NCT00133029. The timing of prophylactic antibiotics in cesarean section and the risk of post-operative febrile morbidity. [ ]
    1. Wax JR, Hersey K, Philput C, Wright MS, Nichols KV, Eggleston MK, et al. Single dose cefazolin prophylaxis for postcesarean infections: before vs after cord clamping. J Matern Fetal Med. 1997;6:61–5.
    1. Thigpen BD, Hood WA, Chauhan S, Bufkin L, Bofill J, Magann E, et al. Timing of prophylactic antibiotic administration in the uninfected laboring gravida: a randomized clinical trial. Am J Obstet Gynecol. 2005;192:1864–8. discussion 1868–71.
    1. Sullivan SA, Smith T, Chang E, Hulsey T, Vandorsten JP, Soper D. Administration of cefazolin prior to skin incision is superior to cefazolin at cord clamping in preventing postcesarean infectious morbidity: a randomized, controlled trial. Am J Obstet Gynecol. 2007;196:455 e1–5.
    1. Yildirim G, Gungorduk K, Guven H, Aslan H, Celikkol Ö, Sudolmus S, et al. When should we perform prophylactic antibiotics in elective cesarean cases? Arch Gynecol Obstet. 2008;280:13–8.
    1. Macones GA, Cleary KL, Parry S, Stamilio DM, Cahill AG, Odibo AO, et al. The Timing of antibiotics at cesarean: a randomized controlled trial. Am J Perinatol. 2012;29:273–6.
    1. Witt A, Petricevic L, Berger A, Germann P, Heinze G, Tempfer C. Antibiotic prophylaxis before surgery vs after cord clamping in elective cesarean delivery. Arch Surg. 2011;146:1404–9.
    1. Gordon HG, Andrew DO, Gunn EV, Regina K, Yngve F-Y, Pablo A-C, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.
    1. Kaimal AJ, Zlatnik MG, Cheng YW, Thiet MP, Connatty E, Creedy P, et al. Effect of a change in policy regarding the timing of prophylactic antibiotics on the rate of postcesarean delivery surgical-site infections. Am J Obstet Gynecol. 2008;199:310 e1–5.
    1. Owens SM, Brozanski BS, Meyn LA, Wiesenfeld HC. Antimicrobial prophylaxis for cesarean delivery before skin incision. Obstet Gynecol. 2009;114:573–9.
    1. Young BC, Hacker MR, Dodge LE, Golen TH. Timing of antibiotic administration and infectious morbidity following cesarean delivery: incorporating policy change into workflow. Arch Gynecol Obstet. 2012;285:1219–24.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren